Impact of blue light on skin pigmentation in patients with melasma
- PMID: 37522494
- PMCID: PMC10315449
- DOI: 10.1111/srt.13401
Impact of blue light on skin pigmentation in patients with melasma
Abstract
Background: The difference in skin pigmentation induced by blue light between melasma patients and healthy people has not been reported. This study aimed to explore the impact of different doses of blue light irradiation on the pigmentation of the skin of non-exposed areas in female melasma patients with III-IV-type skin and healthy women.
Materials and methods: This observational study enrolled patients with melasma and healthy people at the First Affiliated Hospital of Kunming Medical University between January and April 2021. The outcomes were the degree of pigmentation, ΔL*, and ΔITA* values.
Results: Forty-two (21/group) participants were enrolled. After irradiation with different doses of blue light, different degrees of pigmentation could be observed in the irradiated area of the skin of female melasma patients and healthy women. The △L* and △ITA* values in the irradiated area of the skin of healthy women were higher than in female melasma patients after blue light irradiation at 20 J/cm2 (p < 0.05). There were no significant differences in the pigmentation scores, △L* values, and △ITA* values in the irradiated areas of skin at different time points after irradiation with the other doses of blue light (p > 0.05).
Conclusion: Blue light at 20 J/cm2 induced a smaller change in pigmentation in melasma patients than in healthy women, but the effect of blue light at 40-80 J/cm2 was similar.
Keywords: healthy individuals; melasma; observational study; skin pigmentation; visible light.
© 2023 The Authors. Skin Research and Technology published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Evaluation of ex vivo melanogenic response to UVB, UVA, and visible light in facial melasma and unaffected adjacent skin.An Bras Dermatol. 2020 Nov-Dec;95(6):684-690. doi: 10.1016/j.abd.2020.02.015. Epub 2020 Sep 17. An Bras Dermatol. 2020. PMID: 33010989 Free PMC article.
-
Visible light photopatch testing of common photocontactants in female filipino adults with and without melasma: a cross-sectional study.J Drugs Dermatol. 2008 Feb;7(2):149-56. J Drugs Dermatol. 2008. PMID: 18335651
-
Low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser for the treatment of facial melasma in Asians.Dermatol Surg. 2010;36(1):76-87. doi: 10.1111/j.1524-4725.2009.01383.x. Dermatol Surg. 2010. PMID: 20298254 Clinical Trial.
-
Melasma: How hormones can modulate skin pigmentation.J Cosmet Dermatol. 2019 Apr;18(2):458-463. doi: 10.1111/jocd.12877. Epub 2019 Feb 18. J Cosmet Dermatol. 2019. PMID: 30779300 Review.
-
Recent progress in melasma pathogenesis.Pigment Cell Melanoma Res. 2015 Nov;28(6):648-60. doi: 10.1111/pcmr.12404. Epub 2015 Sep 8. Pigment Cell Melanoma Res. 2015. PMID: 26230865 Review.
Cited by
-
Visible Light in the Treatment of Acne Vulgaris.J Cutan Med Surg. 2024 Nov-Dec;28(6):567-571. doi: 10.1177/12034754241265697. Epub 2024 Jul 26. J Cutan Med Surg. 2024. PMID: 39056372 Free PMC article. Review.
References
-
- Rajanala S, Maymone MBC, Vashi NA. Melasma pathogenesis: a review of the latest research, pathological findings, and investigational therapies. Dermatol Online J. 2019;25(10):13030. - PubMed
-
- Sheth VM, Pandya AG. Melasma: a comprehensive update: part I. J Am Acad Dermatol. 2011;65:689‐697. - PubMed
-
- McKesey J, Tovar‐Garza A, Pandya AG. Melasma treatment: an evidence‐based review. Am J Clin Dermatol. 2020;21:173‐225. - PubMed
-
- Ortonne JP, Arellano I, Berneburg M, et al. A global survey of the role of ultraviolet radiation and hormonal influences in the development of melasma. J Eur Acad Dermatol Venereol. 2009;23:1254‐1262. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous